Wu X - Search Results

1

Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer.

Pignata S, Bookman M, Sehouli J, Miller A, Penson RT, Taskiran C, Anderson C, Hietanen S, Myers T, Madry R, Willmott L, Lortholary A, Thomes-Pepin J, Aghajanian C, McCourt C, Stuckey A, Wu X, Nishio S, Copeland LJ, He Y, Molinero L, Patel S, Lin YG, Khor VK, Moore KN. Pignata S, et al. Among authors: wu x. Gynecol Oncol. 2023 Oct;177:20-31. doi: 10.1016/j.ygyno.2023.06.018. Epub 2023 Aug 23. Gynecol Oncol. 2023. PMID: 37625235 Free PMC article. Clinical Trial.

2

Primary extramammary Paget's disease of the vulva: the clinicopathological features and treatment outcomes in a series of 43 patients.

Cai Y, Sheng W, Xiang L, Wu X, Yang H. Cai Y, et al. Among authors: wu x. Gynecol Oncol. 2013 May;129(2):412-6. doi: 10.1016/j.ygyno.2013.02.029. Epub 2013 Feb 27. Gynecol Oncol. 2013. PMID: 23454498

3

Abdominal radical trachelectomy: Is it safe for IB1 cervical cancer with tumors ≥ 2 cm?

Li J, Wu X, Li X, Ju X. Li J, et al. Among authors: wu x. Gynecol Oncol. 2013 Oct;131(1):87-92. doi: 10.1016/j.ygyno.2013.07.079. Epub 2013 Jul 19. Gynecol Oncol. 2013. PMID: 23872192

4

Validation of the new FIGO staging system (2009) for vulvar cancer in the Chinese population.

Li J, Cai Y, Ke G, Xiang L, Wang L, Yang W, Wu X, Yang H. Li J, et al. Among authors: wu x. Gynecol Oncol. 2015 May;137(2):274-9. doi: 10.1016/j.ygyno.2015.03.001. Epub 2015 Mar 7. Gynecol Oncol. 2015. PMID: 25759305

5

Adjuvant concurrent chemoradiation followed by chemotherapy for high-risk endometrial cancer.

Ren Y, Huang X, Shan B, Wu X, Huang X, Shi D, Wang H. Ren Y, et al. Among authors: wu x. Gynecol Oncol. 2016 Jan;140(1):58-63. doi: 10.1016/j.ygyno.2015.11.021. Epub 2015 Nov 24. Gynecol Oncol. 2016. PMID: 26607778 Clinical Trial.

6

Prognostic impact of the time interval from primary surgery to intravenous chemotherapy in high grade serous ovarian cancer.

Feng Z, Wen H, Bi R, Yang W, Wu X. Feng Z, et al. Among authors: wu x. Gynecol Oncol. 2016 Jun;141(3):466-470. doi: 10.1016/j.ygyno.2016.04.016. Epub 2016 Apr 23. Gynecol Oncol. 2016. PMID: 27098361

7

Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.

Pei X, Xiang L, Ye S, He T, Cheng Y, Yang W, Wu X, Yang H. Pei X, et al. Among authors: wu x. Gynecol Oncol. 2017 Dec;147(3):589-596. doi: 10.1016/j.ygyno.2017.09.022. Epub 2017 Sep 24. Gynecol Oncol. 2017. PMID: 28954697

8

Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma.

Zhu J, Wen H, Bi R, Wu Y, Wu X. Zhu J, et al. Among authors: wu y, wu x. J Gynecol Oncol. 2017 Nov;28(6):e77. doi: 10.3802/jgo.2017.28.e77. J Gynecol Oncol. 2017. PMID: 29027395 Free PMC article.

9

Mutational analysis of KRAS and its clinical implications in cervical cancer patients.

Jiang W, Xiang L, Pei X, He T, Shen X, Wu X, Yang H. Jiang W, et al. Among authors: wu x. J Gynecol Oncol. 2018 Jan;29(1):e4. doi: 10.3802/jgo.2018.29.e4. J Gynecol Oncol. 2018. PMID: 29185262 Free PMC article.

10

Metastatic patterns do not provide additional prognostic information for patients with FIGO stage IV high-grade serous ovarian cancer.

Feng Z, Wen H, Ju X, Bi R, Chen X, Yang W, Wu X. Feng Z, et al. Among authors: wu x. J Surg Oncol. 2020 Aug;122(2):315-319. doi: 10.1002/jso.25941. Epub 2020 Jun 4. J Surg Oncol. 2020. PMID: 32500598

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58,874 results

Search Page

Filters